The Surging Demand for Natural Ingredients is Expected to Propel the Growth of the Global Chitin, Chitosan and Derivatives Market During the Forecast Period

Chitin, Chitosan, and Derivatives Market is predicted to reach USD 12.12 Billion  at a CAGR of 14.80% during the forecast period:

Market Research Future (MRFR) has published a cooked research report on the “Global Chitin, Chitosan, and Derivatives Market” that contains information from 2018 to 2032. The Chitin, Chitosan, and Derivatives market is estimated to register a CAGR of 14.80% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global Chitin, Chitosan, and Derivatives market— Advanced Biopolymers AS (Norway), G.T.C. Bio Corporation (China), Golden-Shell Pharmaceutical Co. Ltd. (China), Heppe Medical Chitosan GmbH (Germany), Kitozyme, LLC (Belgium), Zhejiang Shinfuda Marine Biotechnology Corp. (China), Meron Group (India), Primex EHF (Iceland), Zhejiang Candorly Pharmaceutical Co. (China), and Panvo Organics Pvt Ltd (India).

Chitin, Chitosan, and Derivatives Market Highlights

The global Chitin, Chitosan, and Derivatives market is accounted to register a CAGR of 5.90% during the forecast period and is estimated to reach USD 12.12 Billion by 2032.

The chitin, chitosan, and derivatives market involves natural biopolymers extracted from chitin, a component found in shells of crustaceans. Chitosan, a derivative, finds use in various industries like agriculture, healthcare, and food preservation due to its antimicrobial and biocompatible properties. The market's growth is driven by the increasing demand for sustainable and functional materials across diverse applications.

Segment Analysis

The global Chitin, Chitosan, and Derivatives market has been segmented based on Type and Application.

On the basis of Type, the market is segmented into Chitin, Chitosan, Glucosamine, and others. Chitosan accounted for 48% of market revenue (USD 1.7 billion) in 2022, dominating the market. The strong demand for chitosan across a range of industries, including agriculture, aquaculture, food packaging, and medicines, can be credited for the category domination.

Based on Application, the global Chitin, Chitosan, and Derivatives market has been segmented into Food & Beverages, Pharmaceuticals & Nutraceuticals, Animal Feed, Agriculture, and others. The two categories of informatics and pharmaceuticals produced the most market revenue in 2022, accounting for around 41% (or USD 2.3 billion). Due to a growth in the consumption of organic food and beverages, notably in the USA and Europe, the category is predicted to grow fast throughout the anticipated time period.

Regional Analysis

The global Chitin, Chitosan, and Derivatives market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Chitin, Chitosan, and Derivatives market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Chitin, Chitosan, and Derivatives market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Chitin, Chitosan, and Derivatives market comprises of Middle East, Africa, and Latin America.

The North American Chitin, Chitosan, and Derivatives Market dominated this market in 2022 due to growing health consciousness and understanding of the benefits of chitin, chitosan, and its derivatives during the anticipated timeframe. The expansion of the pharmaceutical and nutraceutical sectors will also contribute to the market growth in the North American region.

Due to the rising demand for ecologically friendly and biodegradable products, as well as greater awareness of the benefits of chitin and chitosan derivatives in a range of sectors, the chitin, chitosan, and derivatives market in the Europe area holds the second-highest market share. Furthermore, the UK's market for chitin, chitosan, and derivatives is anticipated to grow and increase significantly in the European region during the anticipated timeframe, although the German market now maintains the greatest market share.

Moreover, during the anticipated timeframe, a rapid growth in the Asia-Pacific Chitin, Chitosan, and Derivatives Market is anticipated. This is a result of the rapid economic growth of developing countries, rapid urbanisation and modernization, growing industry, and a plentiful supply of raw materials. Furthermore, the Indian market for chitin, chitosan, and derivatives is anticipated to rise gradually in the Asia-Pacific region throughout the forecast period, despite China's market dominating the market share.

Key Findings of the Study

• The global Chitin, Chitosan, and Derivatives market is expected to reach USD 12.12 Billion by 2032, at a CAGR of 14.80% during the forecast period.


• The North American Chitin, Chitosan, and Derivatives Market dominated this market in 2022 due to growing health consciousness and understanding of the benefits of chitin, chitosan, and its derivatives during the anticipated timeframe.


• Based on Type, Chitosan accounted for 48% of market revenue (USD 1.7 billion) in 2022, dominating the market


• Advanced Biopolymers AS (Norway), G.T.C. Bio Corporation (China), Golden-Shell Pharmaceutical Co. Ltd. (China), Heppe Medical Chitosan GmbH (Germany), Kitozyme, LLC (Belgium), Zhejiang Shinfuda Marine Biotechnology Corp. (China), Meron Group (India), Primex EHF (Iceland), Zhejiang Candorly Pharmaceutical Co. (China), and Panvo Organics Pvt Ltd (India).